The unified Clinical and Administrative Core will be responsible for administration and coordination of the projects and cores, and organization of the clinical material collection. This core will continue to play a crucial role in the proposed Program Project. The administrative component of this core is responsible for general management of the grant, including processing of purchase orders, maintaining records and protocols, and correspondence pertaining to the projects. The administrative Core will also schedule laboratory meetings, seminar series, and appropriate process for outside review, including the annual meeting of the Advisory Board. The Clinical Component of the core will continue to solicit patient material and coordinate the transport of the clinical specimens to this Program Project. Specifically, the clinical component of the core will identify sources and solicit cell cultures from physician-scientists in contact with patients with EB, and coordinate the transport to the Tissue Culture Core. The Core will also coordinate and facilitate the shipment of blood samples or DNA speciments directly to Project 1 for genetic linkage analysis or to Project 2 for direct examination of mutated DNA sequences. Since the network of collaborators represents an international community of clinician-investigators who live in different continents, careful orchestrating of the clinical activities is a high priority for this core.

Project Start
1996-12-20
Project End
1997-11-30
Budget Start
1996-10-01
Budget End
1997-09-30
Support Year
11
Fiscal Year
1997
Total Cost
Indirect Cost
Name
Thomas Jefferson University
Department
Type
DUNS #
061197161
City
Philadelphia
State
PA
Country
United States
Zip Code
19107
Chung, Hye Jin; Uitto, Jouni (2010) Epidermolysis bullosa with pyloric atresia. Dermatol Clin 28:43-54
Chung, Hye Jin; Uitto, Jouni (2010) Type VII collagen: the anchoring fibril protein at fault in dystrophic epidermolysis bullosa. Dermatol Clin 28:93-105
Mahoney, My G; Sadowski, Sara; Brennan, Donna et al. (2010) Compound heterozygous desmoplakin mutations result in a phenotype with a combination of myocardial, skin, hair, and enamel abnormalities. J Invest Dermatol 130:968-78
Remington, Jennifer; Wang, Xinyi; Hou, Yingpin et al. (2009) Injection of recombinant human type VII collagen corrects the disease phenotype in a murine model of dystrophic epidermolysis bullosa. Mol Ther 17:26-33
Uitto, Jouni (2009) Progress in heritable skin diseases: translational implications of mutation analysis and prospects of molecular therapies*. Acta Derm Venereol 89:228-35
Lugassy, Jennie; McGrath, John A; Itin, Peter et al. (2008) KRT14 haploinsufficiency results in increased susceptibility of keratinocytes to TNF-alpha-induced apoptosis and causes Naegeli-Franceschetti-Jadassohn syndrome. J Invest Dermatol 128:1517-24
Igoucheva, Olga; Kelly, Aislinn; Uitto, Jouni et al. (2008) Protein therapeutics for junctional epidermolysis bullosa: incorporation of recombinant beta3 chain into laminin 332 in beta3-/- keratinocytes in vitro. J Invest Dermatol 128:1476-86
Nakajima, Koji; Tamai, Katsuto; Yamazaki, Takehiko et al. (2008) Identification of Skn-1n, a splice variant induced by high calcium concentration and specifically expressed in normal human keratinocytes. J Invest Dermatol 128:1336-9
Varki, Roslyn; Sadowski, Sara; Uitto, Jouni et al. (2007) Epidermolysis bullosa. II. Type VII collagen mutations and phenotype-genotype correlations in the dystrophic subtypes. J Med Genet 44:181-92
Nyquist, Gurston G; Mumm, Christina; Grau, Renee et al. (2007) Malignant proliferating pilar tumors arising in KID syndrome: a report of two patients. Am J Med Genet A 143:734-41

Showing the most recent 10 out of 333 publications